Trial Profile
Phase 1/2 Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusion in Patients With AJCC Stage IV Renal Cell Carcinoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Cancer vaccine (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions
- Sponsors Genzyme Corporation
- 11 Mar 2008 New trial record.